-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A new drug called Prasugrel has a better anticoagulant effect than a major drug and can be used to treatdiseases such as heartdiseases,according to a new study published Thursday in the online edition of the New England Journal of MedicineBut the drug also increases the risk of severe bleedingThe study says many patients withheartneed anticoagulant drugs to dilute blood and reduce blood clots, and Prasugrel is more effective in this regard than the current mainstream drug PlavixCompared to the latter, patients taking the new drug had a combined risk of having a heart attack,stroke, andhad a lower risk of dying from heart disease
2
0%, and and with faster results, had better results after three days of taking the drug On the other hand
new drugs increase the risk of severe bleeding , which means it is more risky for people older people But deepak Bart, a cardiologist at the Cleveland Clinic, commented it was "a price to pay" for better anticoagulant outcomes The new drug was developed jointly by Lilly and a Japanese company